An Improved and Scalable Process for Celecoxib: A Selective Cyclooxygenase-2 Inhibitor

被引：24
|
作者：
Reddy, Anumula Raghupathi [2 ]
Sampath, Alla [2 ]
Goverdhan, Gilla [2 ]
Yakambaram, Boja [2 ]
Mukkanti, Kagga [1 ,2 ]
Reddy, Padi Pratap [2 ]
机构：
[1] JNT Univ, Inst Sci & Technol, Ctr Environm Sci, Hyderabad 500072, Andhra Pradesh, India
[2] Dr Reddys Labs Ltd, Dept Res & Dev, Integrated Prod Dev, R R Dist 500072, AP, India
来源：
ORGANIC PROCESS RESEARCH & DEVELOPMENT | 2009年 / 13卷 / 01期
关键词：
COX-2; INHIBITORS; DERIVATIVES; PYRAZOLES; SC-58635;
D O I：
10.1021/op800158w
中图分类号：
O69 [应用化学];
学科分类号：
081704 ;
摘要：
An improved, scalable and commercially viable process is developed for an active pharmaceutical ingredient, celecoxib.
引用
收藏
页码：98 / 101
页数：4
相关论文
共 50 条
  • [21] The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis
    Steinbach, G
    Lynch, PM
    Phillips, RKS
    Wallace, MH
    Hawk, E
    Gordon, GB
    Wakabayashi, N
    Saunders, B
    Shen, Y
    Fujimura, T
    Su, LK
    Levin, B
    Godio, L
    Patterson, S
    Rodriguez-Bigas, MA
    Jester, SL
    King, KL
    Schumacher, M
    Abbruzzese, J
    DuBois, RN
    Hittelman, WN
    Zimmerman, S
    Sherman, JW
    Kelloff, G
    NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (26): : 1946 - 1952
  • [22] Effect of cyclooxygenase-2 inhibitor (celecoxib) on the infarcted heart in situ
    Yamamoto, T
    Kakar, NR
    Vina, ER
    Johnson, PE
    Bing, RJ
    PHARMACOLOGY, 2001, 63 (01) : 28 - 33
  • [23] Efficacy and Safety of the Selective Cyclooxygenase-2 Inhibitor Celecoxib in the Treatment of Rheumatoid Arthritis and Osteoarthritis in Japan
    Sakamoto, Choitsu
    Soen, Satoshi
    DIGESTION, 2011, 83 (1-2) : 108 - 123
  • [24] Inhibition of Bacterial Multidrug Resistance by Celecoxib, a Cyclooxygenase-2 Inhibitor
    Kalle, Arunasree M.
    Rizvi, Arshad
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (01) : 439 - 442
  • [25] Cyclooxygenase-2 inhibitor celecoxib:: A possible cause of gastropathy and hypoprothrombinemia
    Linder, JD
    Mönkemüller, KE
    Davis, JV
    Wilcox, CM
    SOUTHERN MEDICAL JOURNAL, 2000, 93 (09) : 930 - 932
  • [26] The cyclooxygenase-2 selective inhibitor celecoxib suppresses proliferation and invasiveness in the human oral squamous carcinoma
    Kwak, Young Eun
    Jeon, Nam Kyeoung
    Kim, Jin
    Lee, Eun Ju
    SIGNAL TRANSDUCTION PATHWAYS, PT C: CELL SIGNALING IN HEALTH AND DISEASE, 2007, 1095 : 99 - 112
  • [27] Assessment of the Potential Ototoxicity of High-Dose Celecoxib, a Selective Cyclooxygenase-2 Inhibitor, in Rats
    Li, Bei
    Su, Kaiming
    Yang, Guang
    Feng, Yanmei
    Xia, Li
    Yin, Shankai
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2015, 152 (06) : 1108 - 1112
  • [28] The Cyclooxygenase-2 Inhibitor Celecoxib Is a Potent Inhibitor of Human Carbonic Anhydrase II
    James F. Knudsen
    Uno Carlsson
    Per Hammarström
    Gerald H. Sokol
    Louis R. Cantilena
    Inflammation, 2004, 28 : 285 - 290
  • [29] The cyclooxygenase-2 inhibitor celecoxib is a potent inhibitor of human carbonic anhydrase II
    Knudsen, JF
    Carlsson, U
    Hammarström, P
    Sokol, GH
    Cantilena, LR
    INFLAMMATION, 2004, 28 (05) : 285 - 290
  • [30] Cardiovascular thrombotic events in arthritis trials of the cyclooxygenase-2 inhibitor celecoxib
    White, W
    Faich, G
    Borer, J
    Makuch, R
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 160 - 161
12345